Han (2020) “CD109 is a potential biomarker for malignant tumors”, American Journal of Translational Medicine, 4(3), pp. 111–121. Available at: https://ajtm.journals.publicknowledgeproject.org/index.php/ajtm/article/view/589 (Accessed: 1 May 2024).